Altimmune, Inc. (NASDAQ: ALT) Director Increases Stake Amid Promising Drug Developments
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameAltimmune, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









